Analyst Ratings for Valeant Pharmaceuticals International Inc. (VRX)

Updated: 2017-07-26

An average rating of Hold has been given to Valeant Pharmaceuticals International Inc. (NYSE:VRX) by analysts covering the stock. A consensus rating of Hold was previously issued for VRX last month.

A buy rating was issued by 3 analysts, 1 gave an overweight rating, 13 gave a hold rating, 1 gave an underweight rating, and 4 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. During this time, the number of analysts bearish on the stock has increased by 0.

Several price targets were given for VRX by the analysts covering the stock. The highest price target was 35, which equates to a potential upside of 95.26 percent. The lowest price target was 8, implying potential capital losses of -55.37 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0.53 percent. That number becomes 0.54 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.27 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -6.2 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 2 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Over the same time period, 2 analysts revised their FY earnings estimates upwards, compared to 2 analysts that revised their FY estimates downwards.

In the last 52-weeks, VRX has achieved a high of 32.75 and a low of 8.31. Today's price is 115.7 percent above the 52-week low, and 45.27 percent below the high. VRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The VRX value stock report compares VRX to some of its peers using value stock charts. The market cap of VRX is $7.72 billion. VRX will post this quarters earnings in days, on 0000-00-00.